Aurobindo Pharma has announced that its 39th Annual General Meeting (AGM) will be held on August 27, 2026. Shareholders can access the Integrated Annual Report for the financial year 2025-26 via a provided web-link and QR code. This notification ensures shareholders are informed and can easily review financial performance and corporate governance details ahead of the meeting.
Integrated Annual Report and AGM Details Released
Aurobindo Pharma Limited is providing shareholders with essential information regarding its upcoming 39th Annual General Meeting (AGM) and the Integrated Annual Report for the financial year ended March 31, 2026. The AGM is scheduled to take place on Thursday, August 27, 2026, commencing at 3:30 p.m. IST and will be conducted through Video Conferencing (VC) or Other Audio-Visual Means (OAVM).
Accessing the Annual Report
In compliance with SEBI Listing Regulations, shareholders who have not registered their email addresses are provided with direct access to the 39th AGM Notice and the Integrated Annual Report 2025-26. A dedicated web-link is available for shareholders to download the report:
Alternatively, the report can be accessed by navigating the company’s website: www.aurobindo.com >>> INVESTORS >>> Results, Reports & Presentations >>> ANNUAL REPORTS >>> Annual Report 2025-26. A QR code is also included in the communication for convenient access.
E-voting and KYC Information
The company has also outlined the e-voting details for the AGM:
- Cut-off date to determine entitlement for e-voting: Thursday, August 20, 2026
- E-voting start date and time: Monday, August 24, 2026 (9:00 a.m. IST)
- E-voting end date and time: Wednesday, August 26, 2026 (5:00 p.m. IST)
Shareholders are reminded of the mandatory requirement to update their PAN, KYC details (including postal address, email address, mobile number, bank account, and nomination details) with their respective Depository Participants or Registrar & Transfer Agent (RTA), KFin Technologies Limited, to ensure uninterrupted services, including dividend payments.
Senior Citizens Investor Cell
Aurobindo Pharma, through its RTA, also highlights the ‘Senior Citizens Investor Cell,’ established to assist senior citizens (above 60 years of age) with their grievances and queries. Communications can be directed to [email protected], and a dedicated toll-free number, 1800 3094 006, is available for support.
Source: BSE
